Literature DB >> 11606597

Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction.

Ramesh Hegde1, Srinivasa M Srinivasula, ZhiJia Zhang, Richard Wassell, Rula Mukattash, Lucia Cilenti, Garrett DuBois, Yuri Lazebnik, Antonis S Zervos, Teresa Fernandes-Alnemri, Emad S Alnemri.   

Abstract

To identify human proteins that bind to the Smac and caspase-9 binding pocket on the baculoviral inhibitor of apoptosis protein (IAP) repeat 3 (BIR3) domain of human XIAP, we used BIR3 as an affinity reagent, followed by elution with the BIR3 binding peptide AVPIA, microsequencing, and mass spectrometry. The mature serine protease Omi (also known as HtrA2) was identified as a mitochondrial direct BIR3-binding protein and a caspase activator. Like mature Smac (also known as Diablo), mature Omi contains a conserved IAP-binding motif (AVPS) at its N terminus, which is exposed after processing of its N-terminal mitochondrial targeting sequence upon import into the mitochondria. Mature Omi is released together with mature Smac from the mitochondria into the cytosol upon disruption of the outer mitochondrial membrane during apoptosis. Finally, mature Omi can induce apoptosis in human cells in a caspase-independent manner through its protease activity and in a caspase-dependent manner via its ability to disrupt caspase-IAP interaction. Our results provide clear evidence for the involvement of a mitochondrial serine protease in the apoptotic pathway, emphasizing the critical role of the mitochondria in cell death.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606597     DOI: 10.1074/jbc.M109721200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  170 in total

1.  Bax oligomerization in mitochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochondrial protein.

Authors:  Xavier Roucou; Sylvie Montessuit; Bruno Antonsson; Jean-Claude Martinou
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

2.  Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation.

Authors:  Deepak Nijhawan; Min Fang; Elie Traer; Qing Zhong; Wenhua Gao; Fenghe Du; Xiaodong Wang
Journal:  Genes Dev       Date:  2003-06-03       Impact factor: 11.361

3.  A novel role for XIAP in copper homeostasis through regulation of MURR1.

Authors:  Ezra Burstein; Lakshmanan Ganesh; Robert D Dick; Bart van De Sluis; John C Wilkinson; Leo W J Klomp; Cisca Wijmenga; George J Brewer; Gary J Nabel; Colin S Duckett
Journal:  EMBO J       Date:  2003-12-18       Impact factor: 11.598

Review 4.  Effector lymphocytes in islet cell autoimmunity.

Authors:  Pere Santamaria
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

5.  Controlling TRAIL-mediated caspase-3 activation.

Authors:  O Micheau; D Mérino
Journal:  Leukemia       Date:  2004-10       Impact factor: 11.528

Review 6.  Mitochondrial function in apoptotic neuronal cell death.

Authors:  Samantha L Budd Haeberlein
Journal:  Neurochem Res       Date:  2004-03       Impact factor: 3.996

Review 7.  The protein structures that shape caspase activity, specificity, activation and inhibition.

Authors:  Pablo Fuentes-Prior; Guy S Salvesen
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

8.  Specific alterations of the HtrA2/HAX-1 ratio in the penumbra upon focal cerebral ischemia in mice.

Authors:  A Rami; A Langhagen
Journal:  Neurochem Res       Date:  2011-11-06       Impact factor: 3.996

Review 9.  Fas death receptor signalling: roles of Bid and XIAP.

Authors:  T Kaufmann; A Strasser; P J Jost
Journal:  Cell Death Differ       Date:  2011-09-30       Impact factor: 15.828

10.  The AF4-mimetic peptide, PFWT, induces necrotic cell death in MV4-11 leukemia cells.

Authors:  Christine M Palermo; Cecily A Bennett; Amanda C Winters; Charles S Hemenway
Journal:  Leuk Res       Date:  2007-09-17       Impact factor: 3.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.